HAVN Life Sciences Inc. (HAVLF)

HAVN Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020
Period Ending	May 2, 2025	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	1	8	61	-
Market Cap Growth	-96.69%	-86.34%	-	-
Enterprise Value	1	8	50	-
Last Close Price	0.00	1.50	17.58	-
PS Ratio	1.41	38.69	-	-
PB Ratio	0.99	3.41	5.70	-
P/TBV Ratio	0.99	4.85	7.33	-
EV/Sales Ratio	1.48	37.11	-	-
Debt / Equity Ratio	0.03	0.12	0.04	-
Asset Turnover	0.08	0.03	-	-
Inventory Turnover	0.35	0.25	-	-
Quick Ratio	0.60	2.26	13.44	39.33
Current Ratio	2.68	4.51	14.84	47.25
Return on Equity (ROE)	-234.52%	-274.69%	-402.36%	-
Return on Assets (ROA)	-30.27%	-54.49%	-150.06%	-
Return on Capital (ROIC)	-32.50%	-58.02%	-156.09%	-
Earnings Yield	-1896.16%	-209.82%	-40.37%	-
FCF Yield	-	-74.59%	-13.89%	-
Buyback Yield / Dilution	-84.53%	-118.42%	-1782.66%	-

Updated Apr 4, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.